临床和实验医学杂志
臨床和實驗醫學雜誌
림상화실험의학잡지
JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE
2014年
19期
1610-1613
,共4页
子痫前期%抗心磷脂抗体%β2糖蛋白Ⅰ%妊娠结局
子癇前期%抗心燐脂抗體%β2糖蛋白Ⅰ%妊娠結跼
자간전기%항심린지항체%β2당단백Ⅰ%임신결국
Preeclampsia%Anti-cardiolipin antibodies%β2 glycoprotein Ⅰ%Pregnancy outcomes
目的:探讨子痫前期患者抗心磷脂抗体( ACA)、抗β2糖蛋白Ⅰ(β2-GPⅠ)水平与妊娠结局的关系。方法选择轻度子痫前期组36例、重度子痫组28例、对照组32例,检测血ACA-IgM、ACA-IgG与抗(β2-GPⅠ)水平,并记录妊娠结局。结果重度前期组患者血清ACA-IgG、ACA-IgM、抗β2-GPⅠ水平显著高于轻度子痫前期组和对照组;轻度子痫前期组患者血清ACA-IgG、ACA-IgM、抗β2-GPⅠ水平显著高于对照组。早产的子痫前期患者血清ACA-IgG、ACA-IgM、抗β2-GPⅠ水平均显著高于足月产的子痫前期患者。胎儿生长受限的子痫前期患者血清ACA-IgM显著高于对照组,ACA-IgG、ACA-IgM、抗β2糖蛋白Ⅰ两两之间均存在显著的相关性( P均<0.05)。结论抗心磷脂抗体与抗β2糖蛋白Ⅰ抗体参与了子痫前期的发生发展过程。
目的:探討子癇前期患者抗心燐脂抗體( ACA)、抗β2糖蛋白Ⅰ(β2-GPⅠ)水平與妊娠結跼的關繫。方法選擇輕度子癇前期組36例、重度子癇組28例、對照組32例,檢測血ACA-IgM、ACA-IgG與抗(β2-GPⅠ)水平,併記錄妊娠結跼。結果重度前期組患者血清ACA-IgG、ACA-IgM、抗β2-GPⅠ水平顯著高于輕度子癇前期組和對照組;輕度子癇前期組患者血清ACA-IgG、ACA-IgM、抗β2-GPⅠ水平顯著高于對照組。早產的子癇前期患者血清ACA-IgG、ACA-IgM、抗β2-GPⅠ水平均顯著高于足月產的子癇前期患者。胎兒生長受限的子癇前期患者血清ACA-IgM顯著高于對照組,ACA-IgG、ACA-IgM、抗β2糖蛋白Ⅰ兩兩之間均存在顯著的相關性( P均<0.05)。結論抗心燐脂抗體與抗β2糖蛋白Ⅰ抗體參與瞭子癇前期的髮生髮展過程。
목적:탐토자간전기환자항심린지항체( ACA)、항β2당단백Ⅰ(β2-GPⅠ)수평여임신결국적관계。방법선택경도자간전기조36례、중도자간조28례、대조조32례,검측혈ACA-IgM、ACA-IgG여항(β2-GPⅠ)수평,병기록임신결국。결과중도전기조환자혈청ACA-IgG、ACA-IgM、항β2-GPⅠ수평현저고우경도자간전기조화대조조;경도자간전기조환자혈청ACA-IgG、ACA-IgM、항β2-GPⅠ수평현저고우대조조。조산적자간전기환자혈청ACA-IgG、ACA-IgM、항β2-GPⅠ수평균현저고우족월산적자간전기환자。태인생장수한적자간전기환자혈청ACA-IgM현저고우대조조,ACA-IgG、ACA-IgM、항β2당단백Ⅰ량량지간균존재현저적상관성( P균<0.05)。결론항심린지항체여항β2당단백Ⅰ항체삼여료자간전기적발생발전과정。
Objective To investigate the relationship of anti-cardiolipin antibodies,anti-β2 glycoproteinⅠlevels in preeclampsia and pregnancy outcomes. Methods 36 patients with mild preeclampsia group,28 patients with severe preeclampsia group and 32 patients in the con-trol group were selected into this study. Blood ACA-IgM,ACA-IgG and anti-β2-GP level Ⅰwere detected,and the outcome of pregnancy was recorded. Results Serum levels of ACA-IgG,ACA-IgM,anti-β2-GP Ⅰin severe preeclampsia group were significantly higher than that in mild preeclampsia and control groups. Serum ACA-IgG,ACA-IgM,anti-β2-GP Ⅰ levels in patients with mild preeclampsia were significantly higher than that of control group. Serum ACA-IgG ,ACA-IgM,anti-β2-GP Ⅰlevels in patients with preeclampsia at preterm delivery were significantly higher that of patients with preeclampsia at term production. Serum ACA-IgM was significantly higher in fetal growth restriction in preeclampsia. Among ACA-IgG,ACA-IgM,anti-β2-GPⅠ levels,this three had significant correlation between any two( P all<0. 05). Conclusion The anti-cardiolipin antibodies and anti-β2-GP Ⅰ antibody involved in the development and progression of pre-eclampsia.